(Q42213358)

18 October 2017

title

MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma (English)

1 reference

18 October 2017

0 references

1 reference

7

1 reference

18 October 2017

8

1 reference

18 October 2017

9

1 reference

18 October 2017

Umberto Gianelli

2

0 references

Marcello Gambacorta

6

object named as

Marcello Gambacorta

1 reference

18 October 2017

Claudia Augello

1

1 reference

18 October 2017

Federica Savi

3

1 reference

18 October 2017

Alessia Moro

4

1 reference

18 October 2017

Emanuela Bonoldi

5

1 reference

18 October 2017

language of work or name

English

0 references

publication date

9 June 2014

1 reference

Journal of Clinical Pathology

18 October 2017

published in

1 reference

18 October 2017

volume

67

1 reference

18 October 2017

issue

8

1 reference

18 October 2017

page(s)

697-701

1 reference

Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management

18 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Molecular signature in HCV-positive lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Hepatitis viruses and non-Hodgkin lymphoma: epidemiology, mechanisms of tumorigenesis, and therapeutic opportunities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Hepatitis C virus and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Viruses, microRNAs, and host interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Emerging roles of small Epstein-Barr virus derived non-coding RNAs in epithelial malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

MicroRNAs in lymphoma, from diagnosis to targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

miR-296 regulation of a cell polarity-cell plasticity module controls tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Liver-specific microRNA-122: Biogenesis and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

The PI3K/Akt pathway as a target in the treatment of hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

Clinicopathologic significance and prognostic value of chromosomal imbalances in diffuse large B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

miR-138 might reverse multidrug resistance of leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

MiR-138 and MiR-135 directly target focal adhesion kinase, inhibit cell invasion, and increase sensitivity to chemotherapy in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

MicroRNA expression profiles of human blood monocyte-derived dendritic cells and macrophages reveal miR-511 as putative positive regulator of Toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

miR-147, a microRNA that is induced upon Toll-like receptor stimulation, regulates murine macrophage inflammatory responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202352

10.1136/JCLINPATH-2014-202352

21 January 2018

Identifiers

DOI

1 reference

18 October 2017

1 reference